MyFinsight
Home
Blog
About
Proceeds from the sale of
product line
$298K
(-38.93%↓ Y/Y)
Net cash provided by
investing activities
$239K
(-30.12%↓ Y/Y)
Canceled cashflow
$59K
Net decrease in cash
and cash...
-$9,167K
(48.19%↑ Y/Y)
Canceled cashflow
$239K
Accrued expenses and
other current and...
$1,318K
(184.05%↑ Y/Y)
Inventory
-$862K
(-41.31%↓ Y/Y)
Stock-based compensation
expense
$613K
(-69.79%↓ Y/Y)
Inventory excess and
obsolescence charge
$298K
(-67.25%↓ Y/Y)
Noncash interest
expense
$240K
(-7.69%↓ Y/Y)
Depreciation expense
$171K
(-50.72%↓ Y/Y)
Amortization of intangible
assets
$95K
(-50.00%↓ Y/Y)
Accounts receivable, net
-$89K
(-109.52%↓ Y/Y)
Income tax expense
$60K
Foreign currency
transaction loss
-$9K
(89.16%↑ Y/Y)
Purchase of property and
equipment
$59K
(-59.59%↓ Y/Y)
Net cash used in
operating activities
-$9,381K
(46.79%↑ Y/Y)
Canceled cashflow
$3,755K
Net cash used in
financing activities
-$15K
(87.39%↑ Y/Y)
Effect of exchange rate
on cash and cash...
-$10K
(96.50%↑ Y/Y)
Net loss
-$11,262K
(46.84%↑ Y/Y)
Accounts payable
-$1,014K
(-126.34%↓ Y/Y)
Prepaid expenses and
other current and...
$838K
(6085.71%↑ Y/Y)
Net changes in
operating lease rou assets...
$22K
(-57.69%↓ Y/Y)
Payment of withholding
taxes related to...
$15K
(-91.67%↓ Y/Y)
Back
Back
Cash Flow
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)
source: myfinsight.com